Clinical Comparison between Glaucoma Triple Procedure and Small Incision Cataract Surgery using Foldable silicone IOL.
- Author:
Hwan Joon CHOI
1
;
Kun Jin YANG
Author Information
1. Department of Ophthalmology, Chonnam University Medical School & Hospital.
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Foldable silicone IOL;
Glaucoma tripe procedure;
Mitomycin C;
Posterior capsular opacification
- MeSH:
Cataract*;
Follow-Up Studies;
Glaucoma*;
Humans;
Incidence;
Jeollanam-do;
Mitomycin;
Postoperative Period;
Prospective Studies;
Rehabilitation;
Silicones*;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
1999;40(3):810-818
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The purpose of this study was to evaluate the postoperative outcomes between the glaucoma triple procedure and the small incision cataract surgery using foldable silicone intraocular lens(IOL). This prospective randomized study comprised of 42 eyes which had the glaucoma triple procedure and 41 eyes which underwent small incision cataract surgery at chonnam University Hospital from May, 1994 to December, 1996. At least 3 months follow-up period was needed. Corrected visual acuity of 0.5 of better was obtained in 50% of triple procedure group and 88% of small incision cataract surgery group with the average lines of improved visual acuity of 5.6 and 7.2 respectively. There was no significant change in the refractive cylinder during the early postoperative period in both group. In the glaucoma triple procedure group, posterior capsular opacification(PCO) developed in significantly low incidence in the Mitomycin C using group and the incidence of PCO in eyes with IOL decentration was greater than in those without IOL decentration. In conclusion, patients who underwent glaucoma triple procedure using foldable silicone IOL showed excellent postoperative IOP control with success rate of 81%, rapid visual rehabilitation and refractive stability. We also found that glaucoma triple procedure with Mitomycin C was associated with lower incidence of PCO.
